Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.
Subscribe to BioPharma Dive - Latest News’s news feed.
Click on “Follow” and decide if you want to get news from BioPharma Dive - Latest News via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to BioPharma Dive - Latest News comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from BioPharma Dive - Latest News which you are really interested in. Click on the blue “Filter” button below to get started.
Title: BioPharma Dive - Latest News